UCLA Hematology/Oncology is a clinical research site located in Santa Monica, California, United States 90404.
Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.
UCLA Hematology/Oncology has participated in 12 clinical trials with 3 currently active.
Therapeutic areas: Non-small Cell Lung Cancer, Metastatic Breast Cancer, Refractory Large B-cell Lymphoma.
Sponsors: Pfizer, Genentech, Inc., Kite, A Gilead Company.
Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
UCLA Hematology/Oncology has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UCLA Hematology/Oncology has 12 clinical trials on record, with 3 currently active. Their work covers Non-small Cell Lung Cancer, Metastatic Breast Cancer, Refractory Large B-cell Lymphoma.
Yes — UCLA Hematology/Oncology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.